Bioventus Inc.

14.82+0.0500+0.34%Vol 62.16K1Y Perf -23.22%
Apr 16th, 2021 16:00 DELAYED
BID14.82 ASK15.57
Open14.80 Previous Close14.77
Pre-Market- After-Market-
 - -  - -%
Target Price
20.33 
Analyst Rating
— — 0.00
Potential %
37.18 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     46.47
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     62.15
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap842.15M 
Earnings Rating
Price Range Ratio 52W %
46.52 
Earnings Date
12th May 2021

Today's Price Range

14.4415.00

52W Range

10.7419.51

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Neutral
Performance
1 Week
7.78%
1 Month
5.86%
3 Months
-
6 Months
-
1 Year
-23.22%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BVS14.820.05000.34
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Earnings HistoryEstimateReportedSurprise %
Q04 2020-2.32-
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date12th May 2021
Estimated EPS Next Report0.04
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume62.16K
Shares Outstanding56.83M
Trades Count763
Dollar Volume2.02M
Avg. Volume285.84K
Avg. Weekly Volume140.46K
Avg. Monthly Volume244.10K
Avg. Quarterly Volume285.84K

Bioventus Inc. (NASDAQ: BVS) stock closed at 14.82 per share at the end of the most recent trading day (a 0.34% change compared to the prior day closing price) with a volume of 62.34K shares and market capitalization of 842.15M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 680 people. Bioventus Inc. CEO is Kenneth M. Reali.

The one-year performance of Bioventus Inc. stock is -23.22%, while year-to-date (YTD) performance is %. BVS stock has a five-year performance of %. Its 52-week range is between 10.74 and 19.51, which gives BVS stock a 52-week price range ratio of 46.52%

Bioventus Inc. currently has a PE ratio of 46.20, a price-to-book (PB) ratio of 5.59, a price-to-sale (PS) ratio of 1.76, a price to cashflow ratio of 10.60, a PEG ratio of 2.32, a ROA of 3.39%, a ROC of 9.83% and a ROE of 11.51%. The company’s profit margin is 4.58%, its EBITDA margin is 19.60%, and its revenue ttm is $321.16 Million , which makes it $7.83 revenue per share.

Of the last four earnings reports from Bioventus Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.04 for the next earnings report. Bioventus Inc.’s next earnings report date is 12th May 2021.

The consensus rating of Wall Street analysts for Bioventus Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Bioventus Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bioventus Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bioventus Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 33.93, ATR14 : 0.44, CCI20 : -18.42, Chaikin Money Flow : -0.19, MACD : 0.95, Money Flow Index : 36.33, ROC : -4.02, RSI : 30.32, STOCH (14,3) : 55.21, STOCH RSI : 1.00, UO : 53.77, Williams %R : -44.79), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bioventus Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Bioventus Inc.

Bioventus Inc is a medical technology company. The Company is engaged in developing and commercializing orthobiologic products for the treatment of patients suffering from a broad array of musculoskeletal conditions.

CEO: Kenneth M. Reali

Telephone: +1 919 474-6700

Address: 4721 Emperor Boulevard, Durham 27703, NC, US

Number of employees: 680

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits